Gibraltar, vaccine failure
June 16, 2026
28 min
Full
177 of 364

June 16, 2026
Gibraltar, vaccine failure
0:00 / 28:36
Excerpt playback isn’t available for this episode — use the full-episode link.
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
Dr John Campbell Episodes Around June 16, 2026
Episode 177 of 364 — walk the feed in the order it was published.
28:36This episodeGibraltar, vaccine failure
Summary
Gibraltar
Population, 33,691
Has administered at least 94,469 vaccine doses
Enough to have fully vaccinated 140.2% of the country’s population.
Face masks required in all shops and supermarkets, public transport, in medical centres, indoor funerals, Airport.
https://www.worldometers.info/coronavirus/country/gibraltar/
Europe
https://www.who.int/emergencies/diseases/novel-coronavirus-2019
World Health Organization
Europe remains “in the firm grip”
Death toll could top 2.2 million this winter
Another 700,000 deaths by March 1
high or extreme stress in intensive care units (ICUs) in 49 out of 53 countries between now and March 1, 2022
Director for WHO Europe, Hans Kluge
face a challenging winter ahead
vaccine plus
Face masks reduce COVID incidence
by 53 %
Over 160,000 deaths could be prevented (by March 1) if universal mask coverage of 95%
Pascal Soriot, the chief executive of AstraZeneca
https://www.telegraph.co.uk/news/2021/11/23/astrazeneca-jab-could-reason-britain-faring-better-europe-says/
UK not seeing so many hospitalisations relative to Europe despite a high number of cases.
Long term T cell immunity after antibodies wane
Looks like, AstraZeneca initially gives higher levels of T-cells
France, Germany, Spain, Belgium – restricted AZ to the under 65s
UK may have high T cells from natural infection and cross immunity from other coronavirus infections
Government source
European leaders had all these unfounded concerns about AstraZeneca and its use in older people
If you look at the data, you can see us using it early has been incredibly helpful in terms of protecting older and vulnerable people from this disease for longer
Dr Peter English
People whose immune systems have produced a strong T-cell response but a weaker antibody response might be more likely to be infected in the first place
but more likely to be able to fight the infection, and they will be much less likely to develop severe disease
It is plausible that this generated an excellent T-cell response, which means that while people can still be infected and infectious, they are unlikely to be seriously unwell
Prof Matthew Snape, Oxford University
The best T-cell responses seem to come if you give a first dose of the AstraZeneca vaccine followed by Pfizer
Prof Dame Sarah Gilbert
Third jabs may be unnecessary





























